Skip to main content

4 Result(s)

within S. Denizot Remove this filter

and

  1. No Access

    Article

    Umbilical cord blood procalcitonin as a risk factor for mortality in very premature infants

    Fetal inflammatory response syndrome is implicated as a cause of fetal or neonatal injury. We analyzed the relationship between the procalcitonin umbilical cord blood level and neonatal outcome. A total of 237...

    A. Lautridou, P.-Y. Ancel, E. Launay… in European Journal of Clinical Microbiology … (2012)

  2. No Access

    Article

    Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort study

    This article describes a study of procalcitonin (PCT) measured in cord blood as a discriminating marker of early-onset neonatal infection. This was a monocenter retrospective study with prospective collection ...

    N. Joram, J.-B. Muller, S. Denizot… in European Journal of Clinical Microbiology … (2011)

  3. Article

    88 Prolonged Sedation / Analgesia ( S/A ) and 4-Year Outcome in Preterm Newborns: Results from the Epipage Cohort.

    Background: It seems adequate to relieve pain in newborns and necessary to evaluate the benefit/risk ratio of this therapy.Is there a relationship between prolonged S/A and long-term outcome of extremely prete...

    S Denizot, J C Rozé, P Y Ancel, B Larroque, R Carbajal, M Kaminski… in Pediatric Research (2005)

    Download PDF (158 KB)

  4. Article

    89 Two-Course Ibuprofen Therapy to Increase Effectiveness When Standard Therapy Failed to Induce Permanent Ductus Closure.

    Indomethacin is the conventional medical treatment of patent ductus arteriosus (PDA) in preterms, inducing ductal closure in about 70% of the patients. To increase this success rate, it has been recommended to...

    S Denizot, G Caillaux-Varin, A Kuster, J C Rozé, V Gournay in Pediatric Research (2005)

    Download PDF (129 KB)